# Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumors

Source: https://onco.cc/trials/nct06658353/  
OnCo record `nct06658353` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial testing VC004, now recruiting.

## Summary

Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumours is a phase 3 interventional study registered as NCT06658353, led by Jiangsu vcare pharmaceutical technology co., and recruiting on the registry. Official title: Single-arm, Open, Multi-centre Phase III Clinical Study to Assess the Safety and Effectiveness of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumours. Planned enrolment is 54 participants (estimated). The study started in 2025-03-17 and primary completion is expected in 2026-12-30. No results have been posted on ClinicalTrials.gov.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-11
- Tags: ctgov-ingest
- Registry id: NCT06658353
- Phase: 3
- Setting: Single-arm, Open, Multi-center Phase III Clinical Study to Assess the Safety and Effectiveness of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumors
- Sponsor: Jiangsu vcare pharmaceutical technology co.
- Enrolled: 54

## Sources

- ClinicalTrials.gov NCT06658353: https://clinicaltrials.gov/study/NCT06658353

## Connected records

- drugs: [VC004](https://onco.cc/drugs/vc004/)
- terms: [Metastasis](https://onco.cc/terms/metastasis/), [Single-arm trial](https://onco.cc/terms/single-arm/)

---
JSON: https://onco.cc/api/v1/entities/nct06658353.json